Important Litigation Filed Against Makers Or Levaquin

Four recently filed lawsuits could provide the groundwork for future legal action against the makers and marketers of Levaquin, a popular antibiotic with potentially damaging side effects. The law firm of Carey and Danis publicly announced their filing of four lawsuits against Johnson and Johnson, Ortho-McNeil Pharmaceutical Inc and Walgreen Co. in what could possibly be a series of landmark cases against the manufacturers and distributors of Levaquin. These civil suits allege that the potentially severe side effects of Levaquin, including severe tendonitis and tendon rupture, were known to the company before marketing the medication. Additionally, through misinformation and obfuscating legitimate data, the company deliberately misled the public and government health officials.

Levaquin belongs to a family of drugs known as quinolones. Specifically, it is classified as a fluoroquinolone, a group of medications used as antibiotics for serious infections where other antibiotics may have proved ineffective. Though there are appropriate applications for these antibiotics, they present potentially damaging side effects. This is especially true of Levaquin (and similarly, Cipro) which has shown to present a potentially debilitating risk of sincere tendonitis and even tendon rupture. Many cases have been reported of the Achilles tendon rupturing in patients taking Levaquin, causing permanent disability.

The lawsuit asserts that Johnson and Johnson and Ortho-McNeil had knowledge of these side effects years before cases began surfacing, yet they continued to market the drug as a safe and viable alternative. Additionally, the lawsuits allege that the two companies manipulated study data in order to circumvent potentially damning evidence against the drug and that the companies minimized the risks to patients when marketing the drug to physicians. The suit charges Johnson and Johnson and Ortho-McNeil with negligence, breach of warranties, and violations of the Illinois Consumer Fraud Act, just to name a few.

Levaquin has been under intense scrutiny for almost a decade; in 2001, the Food and Drug Administration (FDA) instituted initial warning on possible tendon ruptures in patients taking Levaquin. Again in 2004 the FDA issued warnings on Levaquin, expanding the risk of potential tendon rupture from an isolated incident with the Achilles tendon to other tendons in the body, as well as adding the risk of rupture for a period of time after taking the medication. Through 2007 and 2008, the FDA instituted a requirement for the packing of Levaquin, requiring an extended side effect list to be present with the medication as well as giving the drug the FDA's strongest warning label, the Black Box label. The FDA has been quoted recently saying that Levaquin, , "poses a serious and significant public health concern."

You have read the best review article categorized by IRS Tax Attorney and the title Important Litigation Filed Against Makers Or Levaquin. You can bookmark or spread this post by using this URL http://attorneysearchtips.blogspot.com/2012/07/important-litigation-filed-against.html. Thank You!